371 filings
6-K
GMAB
Genmab
22 Apr 24
Current report (foreign)
4:14pm
6-K
GMAB
Genmab
16 Apr 24
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
10:07am
6-K
GMAB
Genmab
15 Apr 24
Current report (foreign)
1:17pm
6-K
GMAB
Genmab
8 Apr 24
Current report (foreign)
1:41pm
6-K
GMAB
Genmab
3 Apr 24
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
6:19am
6-K
5dh88vkcta631 uaw4
2 Apr 24
Current report (foreign)
9:10am
6-K
djkcbhaffikvf p4pi
25 Mar 24
Current report (foreign)
2:13pm
6-K
9q9dalrh3q2o8i09be
21 Mar 24
Current report (foreign)
3:28pm
6-K
9r73g
18 Mar 24
Completion of share buy-back program
4:37pm
6-K
cg2x iiegx9c8ylah
15 Mar 24
Genmab Announces Initiation of Share Buy-Back Program
9:46am
6-K
pgwi2m ssc8s7rzc
13 Mar 24
Current report (foreign)
5:10pm
6-K
3qkwytht
13 Mar 24
Passing of Genmab A/S’ Annual General Meeting
11:34am
6-K
tvl c754gd
11 Mar 24
Current report (foreign)
1:43pm
6-K
nqbaeoe 3zr2c6520q
4 Mar 24
Current report (foreign)
1:50pm
6-K
xzgjclymoccqm z8cp
4 Mar 24
Current report (foreign)
1:26pm
6-K
zb3khv9w
1 Mar 24
Current report (foreign)
6:38pm
6-K
2mja09wnyqb
29 Feb 24
Current report (foreign)
11:47am
6-K
jbt7mj tff
28 Feb 24
Current report (foreign)
11:06am
6-K
pbw t9h5o4w
27 Feb 24
Capital Increase in Genmab as a Result of Employee Warrant Exercise
4:55pm
6-K
qsv55v2zbsxr9z
26 Feb 24
Current report (foreign)
12:19pm